Opportunity ID: 146134

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: W81XWH-12-BCRP-CTR
Funding Opportunity Title:: DOD Breast Cancer Clinical Translational Research Award
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Science and Technology and other Research and Development
Category Explanation::
Expected Number of Awards:: 3
Assistance Listings Number(s):: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 1
Posted Date:: Feb 23, 2012
Last Updated Date::
Original Closing Date for Applications:: Aug 15, 2012
Current Closing Date for Applications:: Aug 15, 2012
Archive Date:: Sep 14, 2012
Estimated Total Program Funding:: $ 9,000,000
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility::

Additional Information

Agency Name:: Dept. of the Army — USAMRAA
Description:: The BCRP Clinical Translational Research (CTR) Award is intended to promote significant improvements over current approaches to breast cancer prevention and therapy, such as studies that will prevent primary or recurrent breast cancer and studies that may result in a new treatment to prevent breast cancer progression to metastasis. The CTR Award supports research projects that are likely to have a major impact on breast cancer by applying promising research findings to patients with, or populations at risk for, breast cancer.
Principal Investigators (PIs) and their collaborators may have originated projects in their laboratories that will form the basis for 1-2 years of advanced translational research leading to a prospective clinical trial to be conducted during this award period. Alternatively, PIs may leverage partnerships with industry. The ability to conduct the required translational research and early phase clinical trial during the award period must be demonstrated.
Applications must include preliminary data and a solid rationale to support the feasibility of advancing novel translational research to a prospective clinical trial. Due to the short period for the advanced translational research phase, PIs must have already demonstrated proof of concept and efficacy in an in vivo system at the time of application submission. Applications also must include a clear experimental plan and a properly powered statistical plan to perform the clinical trial. Investigators must demonstrate availability of and access to an appropriate patient population that will support meaningful clinical outcomes.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings: 12.420
Competition ID:
Competition Title:
Opportunity Package ID: PKG00099432
Opening Date: Feb 23, 2012
Closing Date: Aug 15, 2012
Agency Contact Information:: CDMRP Help Desk: 301-682-5507; help@cdmrp.org
Who Can Apply:: Organization Applicants
mendatory_forms SF424 (R & R) [V1.2]
Project/Performance Site Location(s) [V1.4]
Research & Related Budget [V1.1]
Attachments [V1.1]
optional_forms R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2]
Research And Related Senior/Key Person Profile (Expanded) [V1.2]

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
12.420 PKG00099432 Feb 23, 2012 Aug 15, 2012 View CDMRP Help Desk: 301-682-5507; help@cdmrp.org Organization Applicants